FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

ANTI-CARDIOLIPIN, MULTIPLE AUTOANTIBODIES IMMUNOLOGICAL TEST SYSTEM

K Number: K003069 · Decision Nov 27, 2000
Classifications
1
FEI Numbers
25
Registration Numbers
25
Same Product Code
93
Applicant Total
25
Review Days
56

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
ANTI-CARDIOLIPIN, MULTIPLE AUTOANTIBODIES IMMUNOLOGICAL TEST SYSTEM
K Number
K003069
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
866.5660
Medical Specialty
Immunology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Quest Intl., Inc.
Date Received
October 2, 2000
Decision Date
November 27, 2000
Product Code
MID
Advisory Committee
Immunology
Review Advisory Committee
IM
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MID System, Test, Anticardiolipin Immunological

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (MID), ordered by most recent decision date.

View all

Other Clearances by Quest Intl., Inc.

K Number Device Name
K091260 SERAQUEST EBV EA-D IGG TEST
K033915 MODIFICATION TO SERAQUEST EB VCA IGG
K033780 MODIFICATION TO SERAQUEST VCA IGM
K023593 SERAQUEST ANTI-THYROID PEROXIDASE (TPO)
K023592 SERAQUEST ANTI-THYROGLOBULIN
K991975 SERAQUEST EB NA IGG
K990410 SERAQUEST EB VCA IGG
K990977 SERAQUEST EB VAC IGM
K982485 SERAQUEST CMV IGM
K982281 SERAQUEST RUBELLA IGM
Search all 25 clearances from Quest Intl., Inc. →